• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌少症性肥胖与代谢综合征密切相关。

Sarcopenic obesity is closely associated with metabolic syndrome.

机构信息

Department of Family Medicine, National Taiwan University, Yun-Lin Branch, Taiwan.

出版信息

Obes Res Clin Pract. 2013 Jul-Aug;7(4):e301-7. doi: 10.1016/j.orcp.2012.02.003.

DOI:10.1016/j.orcp.2012.02.003
PMID:24306159
Abstract

OBJECTIVES

Obesity is a risk factor for metabolic syndrome (MetS). We aimed to investigate whether sarcopenic obesity (SO) was associated with MetS.

METHODS

A total of 600 community-dwelling males and females aged 63.6 ± 10.1 years in Northern Taiwan were enrolled in this study. Sarcopenia was defined by the percentage of total skeletal mass (total skeletal muscle mass (kg)/weight (kg) x 100). Cut-offs were established at <37% in men and <27.6% in women using the bioelectrical impedance analysis (BIA) method. Obesity was defined as body mass index (BMI) ≥25 kg/m(2). MetS was defined by the consensus of National Cholesterol Education Program-Adult Treatment Panel III modified for Asians. The association between MetS and SO was examined using multivariate logistic regression analyses after controlling potential confounders.

RESULTS

The SO group demonstrated a higher risk for MetS (odds ratio [OR] 11.59 [95% confidence interval [CI] 6.72-19.98]) than the obese group (7.53 [4.01-14.14]) and sarcopenic group (1.98 [1.25-3.16]). The individual components including waist circumference, serum triglycerides, high-density lipoprotein cholesterol (HDL-C), and fasting serum glucose were independently associated with SO.

CONCLUSION

SO is a major risk factor for MetS. The BIA method and BMI can easily identify subjects at high risk for MetS. The underlying mechanism for the relationship between SO and MetS warrants further research.

摘要

目的

肥胖是代谢综合征(MetS)的一个危险因素。我们旨在研究肌少症性肥胖(SO)是否与 MetS 相关。

方法

本研究共纳入了台湾北部 600 名年龄为 63.6±10.1 岁的社区居住的男性和女性。肌少症定义为全身骨骼质量的百分比(全身骨骼肌质量(kg)/体重(kg)x100)。使用生物电阻抗分析(BIA)方法,男性的截断值<37%,女性的截断值<27.6%。肥胖定义为体质指数(BMI)≥25kg/m²。MetS 采用经亚洲人改良的国家胆固醇教育计划-成人治疗专家组 III 共识定义。在控制潜在混杂因素后,采用多变量逻辑回归分析检查 MetS 与 SO 之间的关联。

结果

与肥胖组(7.53[4.01-14.14])和肌少症组(1.98[1.25-3.16])相比,SO 组发生 MetS 的风险更高(比值比[OR]11.59[95%置信区间[CI]6.72-19.98])。腰围、血清甘油三酯、高密度脂蛋白胆固醇(HDL-C)和空腹血糖等个体成分与 SO 独立相关。

结论

SO 是 MetS 的一个主要危险因素。BIA 方法和 BMI 可以很容易地识别出发生 MetS 风险较高的人群。SO 与 MetS 之间的关系的潜在机制需要进一步研究。

相似文献

1
Sarcopenic obesity is closely associated with metabolic syndrome.肌少症性肥胖与代谢综合征密切相关。
Obes Res Clin Pract. 2013 Jul-Aug;7(4):e301-7. doi: 10.1016/j.orcp.2012.02.003.
2
Adiposity measurements in association with metabolic syndrome in older men have different clinical implications.老年男性中肥胖测量与代谢综合征的关联具有不同的临床意义。
Nutr Res. 2014 Mar;34(3):219-25. doi: 10.1016/j.nutres.2014.01.004. Epub 2014 Jan 24.
3
Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.骨骼肌减少性肥胖与代谢综合征和胰岛素抵抗的关系:老年人五年的协和健康与衰老男性研究。
Exp Gerontol. 2018 Jul 15;108:99-105. doi: 10.1016/j.exger.2018.04.006. Epub 2018 Apr 9.
4
Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.成人的代谢综合征概况、肥胖指标及膳食脂肪酸摄入量:德黑兰脂质与血糖研究
J Hum Nutr Diet. 2014 Apr;27 Suppl 2:98-108. doi: 10.1111/jhn.12117. Epub 2013 Jun 4.
5
Risk of metabolic syndrome in postmenopausal breast cancer survivors.绝经后乳腺癌幸存者的代谢综合征风险。
Menopause. 2013 Apr;20(4):448-54. doi: 10.1097/gme.0b013e318272bd4a.
6
Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.巴西绝经后女性的代谢综合征及其相关危险因素。
Climacteric. 2009 Oct;12(5):431-8. doi: 10.1080/13697130902718168.
7
Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women.空腹血糖水平在正常范围内升高与老年女性代谢综合征风险增加相关。
Eur J Intern Med. 2013 Jul;24(5):425-9. doi: 10.1016/j.ejim.2013.03.013. Epub 2013 May 3.
8
Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.血清瘦素对肥胖和非肥胖患者代谢综合征的影响。
Arch Med Res. 2011 Apr;42(3):244-51. doi: 10.1016/j.arcmed.2011.05.005.
9
Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.20岁及以上菲律宾成年人代谢综合征的患病率。
Asia Pac J Clin Nutr. 2003;12(3):271-6.
10
Measures of obesity and metabolic syndrome in Indian Americans in northern California.加利福尼亚北部印度裔美国人的肥胖及代谢综合征测量
Ethn Dis. 2006 Spring;16(2):331-7.

引用本文的文献

1
Relative Grip Strength as a Screening Indicator for Metabolic Syndrome in Korean Adults: A Cross-Sectional Study Using Data from KNHANES.相对握力作为韩国成年人代谢综合征筛查指标的研究:一项基于韩国国家健康与营养检查调查(KNHANES)数据的横断面研究
Medicina (Kaunas). 2025 Aug 16;61(8):1473. doi: 10.3390/medicina61081473.
2
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study.美国成年人非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值与肌少症肥胖之间的关联:一项横断面研究
Prev Med Rep. 2025 Jun 26;56:103151. doi: 10.1016/j.pmedr.2025.103151. eCollection 2025 Aug.
3
Construction of a prediction model for sarcopenic obesity based on machine learning.
基于机器学习构建肌肉减少性肥胖预测模型。
Front Public Health. 2025 Jun 27;13:1576338. doi: 10.3389/fpubh.2025.1576338. eCollection 2025.
4
Pathophysiological Mechanisms Underlying Sarcopenia and Sarcopenic Obesity: A Systematic Review and Meta-Analysis of Biomarker Evidence.肌肉减少症和肌肉减少性肥胖的病理生理机制:生物标志物证据的系统评价和荟萃分析
Int J Mol Sci. 2025 May 26;26(11):5113. doi: 10.3390/ijms26115113.
5
Sarcopenia and adverse surgical outcomes following cholecystectomy.胆囊切除术后的肌肉减少症与不良手术结局
J Anesth. 2025 May 16. doi: 10.1007/s00540-025-03512-y.
6
The association between circadian syndrome and possible sarcopenia in an aging population: A 4-year follow-up study.老年人群中昼夜节律综合征与可能的肌肉减少症之间的关联:一项4年随访研究。
PLoS One. 2025 May 13;20(5):e0323211. doi: 10.1371/journal.pone.0323211. eCollection 2025.
7
Impact of GLP- 1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia.胰高血糖素样肽-1受体激动剂疗法对肌少症高危患者的影响。
Curr Nutr Rep. 2025 Apr 28;14(1):63. doi: 10.1007/s13668-025-00649-w.
8
Association between sarcopenic obesity, obesity, sarcopenia and quality of life in middle-aged and older Chinese: the Guangzhou Biobank Cohort Study.中国中老年人群中肌肉减少性肥胖、肥胖、肌肉减少症与生活质量的关联:广州生物样本库队列研究
Qual Life Res. 2025 Apr 2. doi: 10.1007/s11136-025-03960-9.
9
Myostatin as a plausible biomarker for early stage of sarcopenic obesity.肌肉生长抑制素作为肌少症肥胖早期阶段的一个合理生物标志物。
Sci Rep. 2024 Nov 19;14(1):28629. doi: 10.1038/s41598-024-79534-5.
10
Association of remnant cholesterol with sarcopenia in Korean adults: a nationwide population-based study using data from the KNHANES.韩国成年人残余胆固醇与肌肉减少症的关系:基于全国人口数据的 KNHANES 研究。
Front Endocrinol (Lausanne). 2024 Aug 23;15:1391733. doi: 10.3389/fendo.2024.1391733. eCollection 2024.